Company intelligence
MYOLYN
About MYOLYN
MYOLYN is a medical device company that develops technologies that provide people with paralysis and muscle weakness unprecedented benefits in health, mobility, and independence. Using unique expertise in robotics, controls, and FES (functional electrical stimulation), MYOLYN designs and distributes the MyoCycle, a line of specially-designed activity-based therapy systems for people overcoming spinal cord injury, stroke, multiple sclerosis, and other neurological disorders. The MyoCycle Home is an in-home therapy device designed specifically for home use. The MyoCycle Home's affordability and ease-of-use are making home FES cycling practical and accessible for the first time.
Verified activity
Signals from MYOLYN
4 published signals
Research & Knowledge
MYOLYN published the 2024 meta-analysis by Frazão, Figueiredo, and Cipriano in the Archives of Physical Medicine and Rehabilitation titled Should We Use the Functional Electrical Stimulation-Cycling Exercise in Clinical Practice? Physiological and Clinical Effects Systematic Review With Meta-analysis
Reported by MYOLYN
Products & Services
MYOLYN launched its new MyoSpark line from the same engineering team that designed and tested the MyoCycle in the United States.
Reported by MYOLYN
Partnerships
MYOLYN and Brooks Rehabilitation formalized a collaboration that has been running for about ten years already in July.
Reported by MYOLYN
Research & Knowledge
MYOLYN published a systematic review by van der Scheer and colleagues in the Journal of NeuroEngineering and Rehabilitation (2021) assessing FES cycling evidence for adults with spinal cord injury.
Reported by MYOLYN